Establishing surrogate kidney endpoints for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes

Establishing surrogate kidney endpoints for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes

<p>Objective: Endpoints currently used in lupus nephritis (LN) clinical trials lack uniformity and questionably reflect long‐term kidney survival. The objective of this investigation was to identify short‐term endpoints that predict long‐term kidney outcomes for use in clinical trials.</p&g...

Descripció completa

Dades bibliogràfiques
Autors principals:	Mackay, M, Dall’Era, M, Fishbein, J, Kalunian, K, Lesser, M, Guerrero, J, Levy, DM, Silverman, E, Petri, M, Arriens, C, Lewis, EJ, Korbet, SM, Conti, F, Tesar, V, Hruskova, Z, Borba, EF, Bonfa, E, Chan, T, Rathi, M, Gupta, KL, Jha, V, Hasni, S, West, MR, Solomons, N, Houssiau, FA, Diaz, J, Mejia-Vilet, J, Rovin, BH
Format:	Journal article
Publicat:	Wiley 2019

Ítems similars

P87 Comparison of a voclosporin-based, triple immunotherapy regimen to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV plus AURORA 1 studies and ALMS
per: Kenneth Kalunian, et al.
Publicat: (2024-03-01)

A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
per: Inker, LA, et al.
Publicat: (2023)

Mixed‐effects models for slope‐based endpoints in clinical trials of chronic kidney disease
per: Vonesh, E, et al.
Publicat: (2019)

Rationale for surrogate endpoints and conditional marketing authorization of new therapies for kidney transplantation
per: Naesens, M, et al.
Publicat: (2022)

Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS
per: Kenneth Kalunian, et al.
Publicat: (2024-11-01)

Allograft function as endpoint for clinical trials in kidney transplantation
per: Hilbrands, L, et al.
Publicat: (2022)

Patient-reported outcomes as endpoints in clinical trials of kidney transplantation interventions
per: Tong, A, et al.
Publicat: (2022)

Risk assessment for PFOA and kidney cancer based on a pooled analysis of two studies
per: K. Steenland, et al.
Publicat: (2022-09-01)

Exploring Novel Endpoints for Clinical Trials in Kidney Disease: Challenges and Opportunities
per: Prabir Roy-Chaudhury
Publicat: (2017-05-01)

Proposed definitions of antibody-mediated rejection for use as a clinical trial endpoint in kidney transplantation
per: Roufosse, C, et al.
Publicat: (2022)

Proposed definitions of T cell-mediated rejection and tubulointerstitial inflammation as clinical trial endpoints in kidney transplantation
per: Seron, D, et al.
Publicat: (2022)

A quantitative method for measuring the relationship between an objective endpoint and patient reported outcome measures.
per: Chul Ahn, et al.
Publicat: (2018-01-01)

Kidney age, not kidney disease
per: Stevens, R, et al.
Publicat: (2018)

Horseshoe Kidney in an 80 Year Old with Chronic Kidney Disease
per: Hema Ramkumar, et al.
Publicat: (2009-01-01)

Editorial: Kidney transplantation and immune-mediated nephropathies, Volume II
per: Josep M. Grinyó, et al.
Publicat: (2022-08-01)

Qualifying a Novel Clinical Trial Endpoint (iBOX) Predictive of Long-Term Kidney Transplant Outcomes
per: Amanda Klein, et al.
Publicat: (2023-09-01)

Neuroimaging endpoints in amyotrophic lateral sclerosis
per: Menke, R, et al.
Publicat: (2016)

Impact of Using Alternative Graft Function Endpoints: A Secondary Analysis of a Kidney Transplant Trial
per: Nicholas A. Fergusson, MSc, et al.
Publicat: (2019-04-01)

Biomarkers and surrogate endpoints.
per: Aronson, J
Publicat: (2005)

Absence of renal remission portends poor long-term kidney outcome in lupus nephritis
per: Farah Tamirou, et al.
Publicat: (2021-05-01)

Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients
per: J. R. Bank, et al.
Publicat: (2015-01-01)

Kidney age, not kidney disease
per: Stevens, R, et al.
Publicat: (2019)

Two-temperature LATE-PCR endpoint genotyping
per: Reis Arthur H, et al.
Publicat: (2006-12-01)

04 Biologic disease modifying drugs in SLE
per: Maria Dall’Era
Publicat: (2023-09-01)

Modelling kidney outcomes based on MELD eras - impact of MELD score in renal endpoints after liver transplantation
per: Paulo Ricardo Gessolo Lins, et al.
Publicat: (2022-08-01)

Reduction of T cell subpopulations peripheral blood is a predictor of renal endpoint events in patients with chronic kidney disease
per: QIAO Yu, et al.
Publicat: (2021-03-01)

Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
per: Marianne J. Hjermstad, et al.
Publicat: (2024-06-01)

Complement Inhibition in ANCA-Associated Vasculitis
per: Vladimir Tesar, et al.
Publicat: (2022-07-01)

Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy
per: Vladimir Tesar, et al.
Publicat: (2021-03-01)

Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney
per: N. L. Rukavina Mikusic, et al.
Publicat: (2016-01-01)

A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus Nephritis
per: Samir V. Parikh, et al.
Publicat: (2021-02-01)

Genetic loci influencing kidney function and chronic kidney disease.
per: Chambers, J, et al.
Publicat: (2010)

Modern concept — renal continuum (acute kidney injury, acute kidney disease, chronic kidney disease)
per: A. M. Shutov, et al.
Publicat: (2021-03-01)

Dyslipidemia in kidney receiver
per: S. M. Martirosyan, et al.
Publicat: (2019-06-01)

Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA Nephropathy
per: Nadja Sparding, et al.
Publicat: (2023-07-01)

Tofacitinib improves composite endpoint measures of disease in patients with psoriatic arthritis
per: Helliwell, P, et al.
Publicat: (2018)

A proposal to analyze the progression of non-dialytic chronic kidney disease by surrogate endpoints: introducing parametric survival models
per: Renato Erohildes Ferreira, et al.
Publicat: (2023-05-01)

Transplantation of kidneys from donors with acute kidney injury: Friend or foe?
per: Boffa, C, et al.
Publicat: (2016)

Chronic kidney disease and pregnancy outcomes
per: Dvořák Jan, et al.
Publicat: (2021-10-01)

Assessment of peritubular capillary rarefaction in kidneys of cats with chronic kidney disease
per: Rene E. Paschall, et al.
Publicat: (2023-03-01)